Vaccine production and deliveries o...

Vaccine production and deliveries of Prevnar, a 7-valent pneumococcal conjugate vaccine manufactured by the agency of Wyeth Lederle Vaccines and licensed for use among infants and children, is now considered adequate to permit a respond to the routine vaccination schedule, according to the Center for Disease mastery and Prevention (CDC).

Beginning in August 2001 the invest of Prevnar failed to engage demand, resulting in shortages. To confection the limited supply and render certain protection of children at highest risk, the CDC published interim recommendations for vaccination that called for withholding vaccine from healthy children pair years of age and older and deferring more [i]or[/i] less doses for healthy children les than couple years of age.

According to the original Advisory Committee in succession Immunization Practices recommendations, and more modern guidance from the CDC, all children les than 24 month of age and 24 to 59 month of age who are at increased risk of pneumococcal disease (eg children with sickle enclosed space disease or anatomic asplenia, chronic illness, a cerebrospinal fluid leak, a cochlear implant, or an immunocompromising condition) should be administered the pneumococcal conjugate vaccine. In addition, physicians should consider vaccine for all other children 24 to 59 month of age, with priority given to children 24 to 35 month of age, American Indian/Alaska Native and black children, and those who attend collection child care.

A catch-up schedule for children who are incompletely vaccinated is available at wwwcdcgov The highest priority for catch-up vaccination is to render certain that children less than five years of age at high risk of invasive pneumococcal disease because of medical conditions have received a total series. Second priorities include vaccination of healthy children les than 24 month of age who have not received any doses of pneumococcal conjugate vaccine, and healthy children les than 12 month of age who have not in addition received three doses.

Because of the oftenness of physician visits for children during their first 18 month catch-up vaccination might offer at regularly scheduled visits for in the greatest degree children who receive vaccines from their primary care physician; special notification should be considered for children who have complet their 15-month visit and are not scheduled to be seen again before the visit at age brace years. Programs that provide vaccinations on the contrary do not see children routinely for other reasons also should consider a notification proces to contact undervaccinated or unvaccinated children.

The CDC is investigating situations in which invasive pneumococcal disease come abouts despite vaccination. Physicians are encouraged to report invasive pneumococcal disease occurring in children les than five years of age who have received more than undivided dose of pneumococcal conjugate vaccine to the CDC by the and of state health departments. If pneumococcal isolates are available from vaccinated children, the CDC will perform serotyping to determine whether the strain is a mark included in the vaccine. Additional information is available at www.cdc.gov/nip/ diseases/pneumo/PCV-survrpts/ default.htm.

COPYRIGHT 2003 American Academy of Family Physicians

COPYRIGHT 2003 Gale Group